The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / The Diagnosis Begins With You
Histology Clinical care Precision medicine Molecular Pathology Voices in the Community

The Diagnosis Begins With You

This Breast Cancer Awareness Month, Michele Mitchell reflects on the invaluable role of pathology in the patient journey

By Michele Mitchell 10/13/2026 Opinion 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

Clinical Report: The Diagnosis Begins With You

Overview

This first-person account describes how pathology findings establish a breast cancer diagnosis and inform tumor characterization and treatment decisions. The author also describes patient-facing pathology conversations and advocacy initiatives intended to make diagnostic information more understandable and involve patients in their care.

Background

Breast cancer screening can lead to biopsy when a finding is suspicious, after which pathologists examine tissue to determine whether cancer is present and characterize the tumor. The author reports that her pathology diagnosis of Grade 2 invasive carcinoma informed the course of her care. She argues that understanding tumor biology is necessary to match a tumor with available treatment options. The account also emphasizes the value the author experienced from discussing her tissue slides and diagnosis with her pathologist.

Data Highlights

The article provides no comparative clinical trial or numerical outcome data. It reports that the ASCP Pathology Clinics: Design, Delivery & Impact certificate workshop is a seven-module program.

Key Findings

  • The author describes pathology as the step that confirmed her cancer, identified its type and grade, and assessed markers used to guide treatment decisions.
  • Her own pathology report identified a Grade 2 invasive carcinoma and, in her account, set the course for her care.
  • After viewing her tissue slides through digital pathology and speaking with her pathologist, the author felt more informed and involved in her care.
  • The author volunteers with local, state, and national organizations, including Michigan Medicine, the American Cancer Society's Reach to Recovery program, the Michigan Hospital Association, and the American Society for Clinical Pathology.
  • The author reports that ASCP's Pathology Clinics: Design, Delivery & Impact workshop provides a seven-module roadmap for pathology practices to discuss diagnoses with patients.
  • The author serves as a patient adviser for MyPathologyReport.com, reviewing articles and proposed changes for clarity and patient-friendliness.

Clinical Implications

The author describes pathology reports and direct conversations with pathologists as important sources of diagnostic information for patients. She supports patient-facing approaches, including explanation clinics and clear, patient-friendly reports, based on her experience and advocacy work.

Conclusion

The account presents pathology as central to breast cancer diagnosis and treatment planning, while emphasizing the author's view that accessible explanations can help patients understand their diagnosis and participate in care.

Related Resources & Content

  1. O'Neill SB, Maher MM, O'Reilly S, Journal of Clinical Oncology, 2011 -- Tailored Diagnostics: A Proposal
  2. Battley JE, Collins D, O'Reilly S, Journal of Clinical Oncology, 2014 -- Partner Diagnostics and the “Choosing Wisely” Campaign
  3. ASCO Publications — Partner Diagnostics and the “Choosing Wisely” Campaign
  4. the pathologist — Hello, My Name Is…
  5. Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce
  6. Diagnostic performance of tomosynthesis plus synthetic mammography versus full‐field digital mammography with or without tomosynthesis in breast cancer screening: A systematic review and meta‐analysis - PMC
  7. Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial | Trial Resources | JAMA | JAMA Network

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Michele Mitchell

Patient Adviser and Co-Chair of the University of Michigan Department of Pathology’s Patient and Family Advisory Council, Ann Arbor, Michigan, USA.

More Articles by Michele Mitchell

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.